46
Views
4
CrossRef citations to date
0
Altmetric
Review

Investigational devices for mitral regurgitation: state of the art

, , &
Pages 105-114 | Published online: 09 Jan 2014

References

  • Dal-Bianco JP, Aikawa E, Bischoff J et al. Active adaptation of the tethered mitral valve: insights into a compensatory mechanism for functional mitral regurgitation. Circulation120, 334–342 (2009).
  • Nkomo VT, Gardin JM, Skelton TN et al. Burden of valvular heart diseases: a population-based study. Lancet368, 1005–1011 (2006).
  • Delahaye JP, Gare JP, Viguier E, Delahaye F, de Gevigney G, Milon H. Natural history of severe mitral regurgitation. Eur. Heart J.12(Suppl. B), 5–9 (1991).
  • Bonow RO, Carabello BA, Chatterjee K et al. American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 2008 focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Writing Committee to revise the 1998 guidelines for the management of patients with valvular heart disease. Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J. Am. Coll. Cardiol.52, E1–E142 (2008).
  • Gillinov AM, Cosgrove DM, Blackstone EH et al. Reoperation for failure of mitral valve repair. J. Thorac. Cardiovasc. Surg.113, 467–473 (1997).
  • Wu AH, Aaronson KD, Bolling SF et al. Impact of mitral valve annuloplasty on mortality risk in patients with mitral regurgitation and left ventricular systolic dysfunction. J. Am. Coll. Cardiol.45, 381–387 (2005).
  • Iung B, Baron G, Butchart EG et al. A prospective survey of patients with valvular heart disease in Europe: the Euro Heart Survey on Valvular Heart Disease. Eur. Heart J.24, 1231–1243 (2003)
  • Masson JB, Webb JG. Percutaneous treatment of mitral regurgitation. Circ. Cardiovasc. Interv.2, 140–146 (2009).
  • Alfieri O, Maisano OF. An effective technique to correct anterior mitral leaflet prolapse. J. Card. Surg.14, 468–470 (1999).
  • Maisano F, Vigano G, Calabrese C et al. Quality of life of elderly patients following valve surgery for chronic organic mitral regurgitation. Eur. J. Cardiothorac. Surg.36, 261–266 (2009).
  • Feldman T, Wasserman HS, Herrmann HC et al. Percutaneous mitral valve repair using the edge-to-edge technique: six-month results of the EVEREST Phase I Clinical Trial. J. Am. Coll. Cardiol.46, 2134–2140 (2005).
  • Feldman T, Kar S, Rinaldi M et al. Percutaneous mitral repair with the MitraClip system: safety and midterm durability in the initial EVEREST (Endovascular Valve Edge-to-Edge REpair Study) cohort. J. Am. Coll. Cardiol.54, 686–994 (2009).
  • Naqvi TZ, Buchbinder M, Zarbatany D et al. Edge-to-edge repair utilizing a percutaneous suture device in an animal model. Cathet. Cardiovasc. Interv.69, 525–531 (2007).
  • Webb JG, Maisano F, Vahanian A et al. Percutaneous suture edge-to-edge repair of the mitral valve. EuroInterv.5(1), 86–89 (2009).
  • Aybek T, Risteski P, Miskovic A et al. Seven years’ experience with suture annuloplasty for mitral valve repair. J. Thorac. Cardiovasc. Surg.131, 99–106 (2006).
  • Webb JG, Harnek J, Munt BI et al. Percutaneous transvenous mitral annuloplasty: initial human experience with device implantation in the coronary sinus. Circulation113, 851–855 (2006).
  • Kuck HK, Webb JG, Harnek J et al. Percutaneous treatment of functional mitral regurgitation: interim EVOLUTION study results with the MONARC system. Am. J. Cardiol.100(8 Suppl. 1), 58L (2007).
  • Maniu CV, Patel JB, Reuter DG et al. Acute and chronic reduction of functional mitral regurgitation in experimental heart failure by percutaneous mitral annuloplasty. J. Am. Coll. Cardiol.44, 1652–1661 (2004).
  • Siminiak T, Hoppe UC, Schofer J et al. Effectiveness and safety of percutaneous coronary sinus-based mitral valve repair in patients with dilated cardiomyopathy (from the AMADEUS trial). Am. J. Cardiol.104, 565–570 (2009).
  • Dubreuil O, Basmadjian A, Ducharme A et al. Percutaneous mitral valve annuloplasty for ischemic mitral regurgitation: first in man experience with a temporary implant. Catheter. Cardiovasc. Interv.69, 1053–1061 (2007).
  • Sack S, Kahlert P, Bilodeau L et al. Percutaneous transvenous mitral annuloplasty: initial human experience with a novel coronary sinus implant device. Circ. Cardiovasc. Interv.2, 277–284 (2009).
  • Barlow CW, Ali ZA, Lim E, Barlow JB, Wells FC. Modified technique for mitral repair without ring annuloplasty. Ann. Thorac. Surg.75, 298–300 (2003).
  • Goel R, Witzel T, Dickens D, Takeda PA, Heuser RR. The QuantumCor device for treating mitral regurgitation: an animal study. Catheter Cardiovasc. Interv.74, 43–48 (2009).
  • Maselli D, Guarracino F, Chiaramonti F et al. Percutaneous mitral annuloplasty: an anatomic study of human coronary sinus and its relation with mitral valve annulus and coronary arteries. Circulation114, 377–380 (2006).
  • Rogers JH, Macoviak JA, Rahdert DA et al. Percutaneous septal sinus shortening: a novel procedure for the treatment of functional mitral regurgitation. Circulation113, 2329–2334 (2006).
  • Palacios IF, Condado JA, Brandi S et al. Safety and feasibility of acute percutaneous septal sinus shortening: first-in-human experience. Catheter. Cardiovasc. Interv.69, 513–518 (2007).
  • Grossi EA, Saunders PC, Woo YJ et al. Intraoperative effects of the Coapsys annuloplasty system in a randomized evaluation (RESTOR-MV) of functional ischemic mitral regurgitation. Ann. Thorac. Surg.80, 1706–1711 (2005).
  • Mishra YK, Mittal S, Jaguri P, Trehan N. Coapsys mitral annuloplasty for chronic functional ischemic mitral regurgitation: 1-year results. Ann. Thorac. Surg.81, 42–46 (2006).
  • Pedersen WR, Block P, Leon M et al. iCoapsys mitral valve repair system: percutaneous implantation in an animal model. Catheter. Cardiovasc. Interv.72, 125–131 (2008).
  • Webb JG, Wood DA, Ye J et al. Transcatheter valve-in-valve implantation for failed bioprosthetic heart valves. Circulation121, 1848–1857 (2010).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.